| scholarly article | Q13442814 |
| P50 | author | Kathleen Bennett | Q38523552 |
| P2093 | author name string | Linda Sharp | |
| Kala Visvanathan | |||
| Thomas I Barron | |||
| Evelyn M Flahavan | |||
| P2860 | cites work | Prevalence proportion ratios: estimation and hypothesis testing | Q23922957 |
| Aspirin intake and survival after breast cancer | Q24604280 | ||
| Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival | Q27022747 | ||
| Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status | Q28176257 | ||
| Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial | Q28182721 | ||
| Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer | Q28193375 | ||
| Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer | Q28194496 | ||
| Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort | Q28213690 | ||
| Simulation study of confounder-selection strategies. | Q52884423 | ||
| A prospective validated model for predicting axillary node metastases based on 2,000 sentinel node procedures: the role of tumour location [corrected]. | Q52942795 | ||
| A checklist for medication compliance and persistence studies using retrospective databases. | Q53242661 | ||
| Effectiveness of organised versus opportunistic mammography screening | Q57697115 | ||
| Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases | Q63966512 | ||
| Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond | Q64129432 | ||
| Factors associated with axillary lymph node metastasis from breast carcinoma: descriptive and predictive analyses | Q73094442 | ||
| Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer | Q77601963 | ||
| Easy SAS calculations for risk or prevalence ratios and differences | Q81908646 | ||
| Association between diabetes mellitus and adverse characteristics of breast cancer at presentation | Q83016655 | ||
| NSAID use and breast cancer risk in the VITAL cohort | Q28219138 | ||
| Binomial regression in GLIM: estimating risk ratios and risk differences | Q28299429 | ||
| Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data | Q30664587 | ||
| Analgesic use and sex steroid hormone concentrations in postmenopausal women | Q33780860 | ||
| The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma | Q33927159 | ||
| Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results | Q34001872 | ||
| Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated [...] | Q34113009 | ||
| The sympathetic nervous system induces a metastatic switch in primary breast cancer | Q34134468 | ||
| VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium | Q34254937 | ||
| Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials | Q34263106 | ||
| The role of aspirin in cancer prevention | Q34265633 | ||
| Proper interpretation of non-differential misclassification effects: expectations vs observations | Q34407776 | ||
| Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors | Q34778824 | ||
| Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial | Q35681592 | ||
| COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin | Q35797114 | ||
| Recommendations for presenting analyses of effect modification and interaction | Q35883640 | ||
| Use of aspirin postdiagnosis improves survival for colon cancer patients | Q35927156 | ||
| Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence | Q36267669 | ||
| Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size | Q36615721 | ||
| Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial | Q37019565 | ||
| Low-dose aspirin use and cancer characteristics: a population-based cohort study | Q37214225 | ||
| Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. | Q37996239 | ||
| Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model | Q39340968 | ||
| Interpretation and choice of effect measures in epidemiologic analyses | Q39763211 | ||
| Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications | Q40243316 | ||
| Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study | Q40790232 | ||
| Prospective study of regular aspirin use and the risk of breast cancer | Q41007088 | ||
| Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma | Q44464279 | ||
| Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis | Q44527924 | ||
| Beta blockers and breast cancer mortality: a population- based study | Q44536984 | ||
| Anticoagulant medication at time of needle biopsy for breast cancer in relation to risk of lymph node metastasis | Q44934786 | ||
| Variation in staging and treatment of local and regional breast cancer in the elderly | Q45100743 | ||
| NSAID use and survival after breast cancer diagnosis in post-menopausal women. | Q45143526 | ||
| Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size | Q45245396 | ||
| A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. | Q51625480 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| population-based cohort study | Q108562148 | ||
| P304 | page(s) | 4065-4077 | |
| P577 | publication date | 2014-08-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study | |
| P478 | volume | 74 |
| Q91138510 | Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling |
| Q44586148 | Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis. |
| Q26751511 | Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies |
| Q58696344 | Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial |
| Q47372688 | Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database |
| Q39534421 | De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I-III breast cancer |
| Q31002462 | Generalisability of pharmacoepidemiological studies using restricted prescription data. |
| Q40836898 | Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence |
| Q33687606 | NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis |
| Q38837269 | Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression |
| Q59336315 | No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study |
| Q37736058 | Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-life |
| Q38673155 | Pre-diagnostic statin use, lymph node status and mortality in women with stages I-III breast cancer |
| Q92553227 | Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study |
| Q40767715 | Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
| Q89064907 | Relationship between anti-depressant use and lung cancer survival |
| Q38735032 | Role of Aspirin in Breast Cancer Survival |
| Q49544289 | Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer |
Search more.